Medinova Diagnostic Services Ltd.
BSE: 526301
₹43.45
As on 24-Nov-2025IST
Market cap
₹43 Cr
Revenue (TTM)
₹10 Cr
P/E Ratio
20.2
P/B Ratio
-921.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
0 %
-
ROCE
108 %
-
Industry P/E
53.27
-
EV/EBITDA
12.3
-
Debt to Equity
-4
-
Book Value
₹--
-
EPS
₹2.2
-
Face value
10
-
Shares outstanding
9,981,640
10 Years Aggregate
CFO
₹12.80 Cr
EBITDA
₹18.45 Cr
Net Profit
₹6.18 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medinova Diagno
| 16.6 | 6.8 | 6.0 | 7.4 | 20.2 | 25.5 | 2.7 |
|
BSE Healthcare*
| 6.8 | 11.7 | 10.6 | 10.4 | 26.1 | 14.0 | 11.7 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Medinova Diagno
| -26.3 | 84.9 | -37.1 | 52.2 | 93.9 | -21.7 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Medinova Diagno
Medinova Diagnostic Services Limited, together with its subsidiary, Medinova Millennium MRI Services LLP, provides medical diagnostic services in India. It offers blood test, MRI/CT scan, digital X-ray, ultra-sonography, bone densitometry, 2D echo... color doppler, vascular study, cardiac stress lab, ECG, EEG, biochemistry, haematology, microbiology, and histopathology services; and home visit, lab samples, reports delivery, and ambulance services. The company also provides lipid, cardiac, hypertension, renal, hepatic, orthopedic, and rheumatoid profiles. In addition, it operates a training and research institution in Pune. The company serves company executives, government employees, industrial workers, etc., as well as people in rural and semi urban areas. It operates four centers located in Hyderabad, Kolkata, and Pune; and three franchise centers. The company was founded in 1985 and is based in Hyderabad, India. Medinova Diagnostic Services Limited is a subsidiary of Vijaya Diagnostic Centre Private Limited. Read more
-
Incorporated
1993
-
Chairman
Sura Surendranath Reddy
-
Managing Director
Sunil Chandra Kondapally
-
Headquarters
Hyderabad, Telangana
-
Website
Annual Reports
FAQs for Medinova Diagno
What is the current share price of Medinova Diagnostic Services Ltd Today?
The share price of Medinova Diagnostic Services Ltd is ₹43.45 (BSE) as of 24-Nov-2025 IST. Medinova Diagnostic Services Ltd has given a return of 20.15% in the last 3 years.
What is the current PB & PE ratio of Medinova Diagnostic Services Ltd?
The P/E ratio of Medinova Diagnostic Services Ltd is 20.15 times as on 24-Nov-2025, a 62 discount to its peers’ median range of 53.27 times.
The P/B ratio of Medinova Diagnostic Services Ltd is -921.59 times as on 24-Nov-2025, a 11150 discount to its peers’ median range of 8.34 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.96
|
-30.34
|
|
2024
|
15.28
|
-9.77
|
|
2023
|
10.49
|
-3.40
|
|
2022
|
13.87
|
-4.62
|
|
2021
|
11.28
|
-3.17
|
What is the 52 Week High and Low of Medinova Diagnostic Services Ltd?
The 52-week high and low of Medinova Diagnostic Services Ltd are Rs 46.92 and Rs 32.10 as of 07-May-2026.
What is the market cap of Medinova Diagnostic Services Ltd?
Medinova Diagnostic Services Ltd has a market capitalisation of ₹ 43 Cr as on 24-Nov-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Medinova Diagnostic Services Ltd?
Before investing in Medinova Diagnostic Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.